SUSAN THAGARD HENRY
Real Estate Commission in Pittsburgh, PA
License number
Pennsylvania RS335269
Category
Real Estate Commission
Type
Real Estate Salesperson-Standard
Address
Address
Pittsburgh, PA 15238
Professional information
Marketing Executive At L'occitane
Position:
Marketing executive at L'Occitane
Location:
Greater Pittsburgh Area
Industry:
Cosmetics
Work:
L'Occitane
-
Marketing executive
Polynucleotide Compositions Encoding S-Adenosyl-L-Methionine:phosphoethanolamine N-Methyltransferase And Methods For Modulating Lipid Biosynthesis In Plants
US Patent:
6979732, Dec 27, 2005
Filed:
Mar 15, 2000
Appl. No.:
09/525885
Inventors:
Michael L. Nuccio - Melrose FL, US
Andrew D. Hanson - Gainesville FL, US
Susan A. Henry - Pittsburgh PA, US
Andrew D. Hanson - Gainesville FL, US
Susan A. Henry - Pittsburgh PA, US
Assignee:
University of Florida - Gainesville FL
Carnegie Mellon University - Pittsburgh PA
Carnegie Mellon University - Pittsburgh PA
International Classification:
C07H021/04, C12N001/20
US Classification:
536 232, 4352523, 4352351
Abstract:
Disclosed are compositions and methods for increasing the nutritional value of plants and plant parts. In illustrative embodiments PEAMT and ΔPEAMT polynucleotide and polypeptide compositions are disclosed as well as their use in modulating the levels of lipid compounds, and particularly, regulating the level of phosphatidylcholine, and its precursors in plants and seeds derived therefrom. Also disclosed are methods for modulating the level of glycine betaine and choline-O-sulfate in cells, and increasing the tolerance of transformed plants to osmotic and cryogenic stress.
Inositol-Excreting Yeast
US Patent:
5599701, Feb 4, 1997
Filed:
May 30, 1995
Appl. No.:
8/453461
Inventors:
Susan A. Henry - Pittsburgh PA
Michael J. White - Pittsburgh PA
Michael J. White - Pittsburgh PA
Assignee:
Carnegie Mellon University - Pittsburgh PA
International Classification:
C12P 702, C12P 764, C12N 912, C12N 119
US Classification:
435155
Abstract:
A yeast cell, preferably Saccharomyces cerevisiae, which contains a functional stable recombinant DNA sequence that does not allow for the encoding of a negative regulator of phospholipid biosynthesis therein. In a preferred embodiment, the recombinant DNA sequence is an opil gene deletion which results in the deregulation of inositol or inositol-containing metabolites such as inositol-1-phosphate synthase. Moreover, there is a method for obtaining inositol, inositol-containing metabolites or phospholipids such as myo-inositol or inositol-1-phosphate. The method comprises the steps of genetically engineering a stable yeast cell, preferably Saccharomyces cerevisiae, to continually produce inositol, inositol-containing metabolites or phospholipids. Additionally, there is the step of then generating the inositol, inositol-containing metabolites or phospholipids. In a preferred embodiment, the genetically engineering step includes the step of altering the negative regulatory step involved in phospholipid biosynthesis to overproduce inositol, inositol-containing metabolites or phospholipids such as myo-inositol.
Inositol-Excreting Yeast
US Patent:
5529912, Jun 25, 1996
Filed:
May 30, 1995
Appl. No.:
8/453477
Inventors:
Susan A. Henry - Pittsburgh PA
Michael J. White - Pittsburgh PA
Michael J. White - Pittsburgh PA
Assignee:
Carnegie Mellon University - Pittsburgh PA
International Classification:
C12P 702, C12P 764, C12N 912, C12N 119
US Classification:
435155
Abstract:
A yeast cell, preferably Saccharomyces cerevisiae, which contains a functional stable recombinant DNA sequence that does not allow for the encoding of a negative regulator of phospholipid biosynthesis therein and which has multiple copies of an INO1 gene. In a preferred embodiment, the recombinant DNA sequence is an OPI1 gene deletion which results in the deregulation of inositol or inositol-containing metabolites such as inositol-1-phosphate synthase. Moreover, there is a method for obtaining inositol, inositol-containing metabolites or phospholipids such as myo-inositol or inositol-1-phosphate. The method comprises the steps of genetically engineering a stable yeast cell, preferably Saccharomyces cerevisiae, to continually produce inositol, inositol-containing metabolites or phospholipids. Additionally, there is the step of then generating the inositol, inositol-containing metabolites or phospholipids. In a preferred embodiment, the genetically engineering step includes the step of altering the negative regulatory step involved in phospholipid biosynthesis to overproduce inositol, inositol-containing metabolites or phospholipids such as myo-inositol.
Methods For Producing Phospholipid Metabolites In Yeast
US Patent:
5908752, Jun 1, 1999
Filed:
May 7, 1997
Appl. No.:
8/852450
Inventors:
Susan A. Henry - Pittsburgh PA
Jana L. Patton - Pittsburgh PA
Peter Griac - Bratislava, SK
Sepp D. Kohlwein - Graz, AT
Jana L. Patton - Pittsburgh PA
Peter Griac - Bratislava, SK
Sepp D. Kohlwein - Graz, AT
Assignee:
Carnegie Mellon University - Pittsburgh PA
International Classification:
C12Q 102, C12Q 168, C12N 118
US Classification:
435 6
Abstract:
Methods are provided for increased and controlled production of choline and inositol, choline and inositol metabolites, and choline- and inositol-containing phospholipids in yeast, comprising the step of increasing phosphatidylcholine (PC) turnover in yeast. Methods are also provided for detecting phospholipase D-mediated turnover of phosphatidylcholine in vivo in yeast, comprising an assay for choline excretion.